Follow the Alembic Pharma stock price and the full management transaction log of the company, a publicly traded company based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €160.4bn. The latest transaction was reported on 19 June 2026 (Acquisition). Among the most active insiders: Nirayu Private Limited. Every trade is openly available.
6
Insider Decl.
n/a
Thresholds
€2m
6 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Alembic Pharma Buy (bullish), based on 10 analysts. Average price target: ₹949.30.
32Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,100 of 29,062 companies
59.1
score / 100
Value
48
Quality
71
FCF yld1.8%
Earn yld4.2%
EV/EBITDA15.8x
ROE12%
Gross mgn67%
Net mgn9.4%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
60,000 shares@ ₹758.0038.1% of flowEquity SharesMarket PurchaseSEBI:3660fa3496803de67527703cc3e8ff54a498d345
Canonical exit: 23 Aug 2026 (T+90)
6 of 6 declarations
Acerca de Alembic Pharma
Alembic Pharma es una empresa farmacéutica india que se centra en la investigación, el desarrollo y la fabricación de medicamentos genéricos y productos farmacéuticos. Cotiza en la Bolsa de Bombay con el símbolo XBOM.